BA vs MRSN · P/E 89, rev $24.56B vs rev $40.5M
The Boeing Company (BA) versus Mersana Therapeutics Inc (MRSN) — a side-by-side from cached financials, not a winner call.
The Boeing Company (BA) is a aerospace & defense company listed on NYSE. It is led by Kelly Ortberg.
Mersana Therapeutics Inc (MRSN) is a biotechnology company listed on NASDAQ.
Latest reported BA revenue for 2026-06-30 was $24.56B. Net income was -$444.0M. Revenue was up 10.5% from 2026-03-31 to 2026-06-30. BA currently screens at market cap $177.86B and trailing P/E 89.2.
Latest reported MRSN revenue for 2024-12-31 was $40.5M. Net income was -$69.2M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. MRSN currently screens at market cap $145.4M.
BA currently screens at market cap $177.86B and trailing P/E 89.2. MRSN currently screens at market cap $145.4M.
Not investment advice. Open the BA and MRSN stock pages for the full models.
Not investment advice.